Covered Call Analyzer CONSERVATIVE "STOCKS-TO-CONSIDER"
for November, 2004
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
Dec Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
Enzon Pharma. | ENZN | $14.79 | 600 | $8,894 | QYZLW | $0.90 | $520 | 17.5 | 29% | ($164) | -2% |
| Comments: |
Not called. Sold all shares at $13.65 to close out position after expiration. |
||||||||||
| Rambus, Inc. | RMBS | $20.73 | 400 | $8,312 | BNQLE | $0.60 | $220 | 25 | 28% | +$1,908 | +23% |
| Comments: |
Called. |
||||||||||
|
Career Education Corp |
CECO |
$35.01 |
200 |
$7,022 |
CUYLH |
$1.10 |
$200 |
40 |
20% |
+$1,352 |
+19% |
|
Comments: |
Not called. Sold Jan40 at 1.40. Not called. Sold all shares at $39.47 to close out position. |
||||||||||
| Netflix, Inc. | NFLX | $11.24 | 800 | $9,012 | QNQLS | $0.55 | $420 | 12.5 | 19% | +$1,408 | +16% |
| Comments: |
Called. |
||||||||||
| American Pharma. | APPX | $29.08 | 300 | $8,744 | AQOLZ | $0.80 | $220 | 32.5 | 17% | +$1,226 | +14% |
| Comments: |
Called. |
||||||||||
|
Digene Corp. |
DIGE |
$22.24 | 400 | $8,980 | QDGLE | $0.50 | $180 | 25 | 16% | +$1,200 | +13% |
| Comments: |
Called. |
||||||||||
|
Rambus, Inc. |
RMBS |
$20.73 |
400 |
$8,312 |
BNQLX |
$1.05 |
$400 |
22.5 |
16% |
+$1,088 | +13% |
| Comments: |
Called. |
||||||||||
|
Omnivision Technology |
OVTI | $18.26 | 500 | $9,150 | UCMLD | $0.70 | $330 | 20 | 16% | ($974) | -11% |
| Comments: |
Not called. Sold Jan20 at 0.35. Exercised get-out price at $15.52 after buying back calls at 0.14. |
||||||||||
|
Sina Corp. |
SINA | $36.62 | 200 | $7,344 | NOQLH | $1.05 | $190 | 40 | 14% | ($984) | -13% |
| Comments: |
Exercised get-out price at $31.13 after buying back calls at 0.28. |
||||||||||
|
Ask Jeeves, Inc. |
ASKJ |
$23.75 | 400 | $9,520 | AIKLE | $1.30 | $500 | 25 | 12% | +$980 | +10% |
| Comments: |
Called. |
||||||||||
|
All positions closed out with portfolio value up +$7,041. |
|||||||||||
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.